FDA issued a third CRL for reproxalap, again concluding the NDA lacks substantial evidence of efficacy for dry eye signs and symptoms despite no safety/manufacturing deficiencies. Regulators ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...
WASHINGTON--(BUSINESS WIRE)--FiscalNote Holdings, Inc. (NYSE: NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced the expansion of its PolicyNote API to include its ...
ปรึกษากฎหมายไทยเบื้องต้น ค้นหามาตรา คำนวณค่าชดเชย ประเมินค่าบริการ นัดหมายทนายความ และ ...
LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Mimecast, a global leader in managing human and AI risk, today announced that its complete email security protection stack is now available through ...
Scop3P, an ELIXIR Belgium node service, is focused on phospho-sites on protein 3D structure. Scop3P provides a unique and powerful resource to explore and understand the impact of phospho-sites on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results